An International, Phase III Randomized Trial in Patients With Mucinous Epithelial Ovarian Cancer (mEOC/GOG 0241) With Long-Term Follow-Up: And Experience of Conducting a Clinical Trial in a Rare Gynecological Tumor

Gynecologic Oncology - United States

doi 10.1016/j.ygyno.2019.03.256